Butorphanol Mitigate Emergence Agitation in Patients Undergoing Functional Endoscopic Sinus Surgery

• Status: Recruiting
• Trial end date: 2020-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Emergence agitation is one of the common postoperative complications after functional endoscopic sinus surgery（FESS). The objective of present study is to explore the effectiveness of butorphanol in the alleviation of emergence agitation in patients undergoing Functional Endoscopic Sinus Surgery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: RenJi Hospital
• Treatments: Butorphanol

Criteria

Inclusion Criteria:

1. Age >=18 years,<=65years;

2. height 150-180 cm;

3. weight 55-80 kg;

4. Signed the inform consent

5. American Society of Anesthesiologists classification I to II

6. Select to functional endoscopic sinus surgery

Exclusion Criteria:

1. Existing cerebral disease, or have a history of neurological and psychiatric diseases including Alzheimer Disease, stroke, epilepsy and psychosis;

2. Several audition or vision disorder;

3. Unwillingness to comply with the protocol or procedures.

4. Can not communicated with Chinese Mandarin

5. Existing bradycardiac arrhythmia（Heart rate <60 bpm for any reasons）

6. Existing gastrointestinal ulcer

7. Existing urinary incontinence

8. Existing asthma or chronic obstructive pulmonary disease

9. Allegory to Butorphanol